PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34802947-11	2021	Moreover, the anti-inflammatory effect of PL was evidenced by the maintenance of AnxA1 levels, reduction of COX-2 (p < 0,05), Bcl-2 (p < 0,01) and NF-kB (p < 0,001) expressions and decreased IL-1beta, IL-17 (p < 0,01) and TNF-alpha (p < 0,05) levels.	pl	42-44	tumor necrosis factor	Mus musculus	222-231	
26588227-9	2015	The pro-inflammatory cytokine expression in the mouse colon, including TNF-alpha, IL-6, INF-gamma, IL-17, and IL-1beta, was significantly up-regulated by DSS treatment, but was inhibited upon PL administration.	pl	192-194	tumor necrosis factor	Mus musculus	71-80	
24992758-8	2014	Serum levels of TNF-alpha, IL-2, and IFN-gamma, frequencies of CD4 + and CD8+ T cells in the spleen, and splenic NK and CTL activities were also significantly increased in mice treated with 5-FU+PL or 5-FU+PTM compared with mice treated with 5-FU alone (P &lt; 0.05).	pl	195-197	tumor necrosis factor	Mus musculus	16-25	
22249932-3	2012	RESULTS: PL caused peribronchial and perivascular inflammation that peaked at 18-24 h. Polymorphonuclear cells (PMNs) began to accumulate in bronchoalveolar lavage fluid (BALF) of PL-challenged mice by 4 h and accounted for &gt;90% of leukocytes by 18-24 h. Inflammation was marked by the appearance of MIP-2, KC, TNF-alpha, and IL-6 in the BALF with peak levels attained 4 h after PL administration.	pl	9-11	tumor necrosis factor	Mus musculus	314-323